Letybo

Those two vertical lines between your brows have a way of saying things you never meant to say. Tired. Annoyed. Stressed. Even on a great day, they can make your face read more serious than you feel. Letybo is the newest FDA-approved neurotoxin for exactly those lines, and Rejuvalase is now offering it in Santa Barbara. If you have been curious about neurotoxin already love your current toxin, or simply want to know what the newest option can do, here is what to know. What is Letybo? Letybo (letibotulinumtoxinA) is a botulinum toxin type A injectable, in the same family as Botox, Dysport, Xeomin, and Daxxify. It was approved by the FDA in 2024 for the temporary improvement of moderate to severe frown lines, the "11s" between the eyebrows. It is new to the U.S., but not new to the world. Letybo is made by Hugel, a South Korean aesthetics company, and has been a leading neurotoxin in South Korea for years, used in more than 50 countries under the name Botulax. U.S. approval followed three phase III clinical trials with more than 1,000 participants across the United States and Europe. BOOK NOW